Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts

@article{Zhu2014MesenchymalSC,
  title={Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts},
  author={Yin Zhu and M. Cheng and Z. Yang and Chunyan Zeng and Jiang Chen and Yong-hui Xie and Shi-Wen Luo and Kun-He Zhang and S. Zhou and N. Lu},
  journal={Drug Design, Development and Therapy},
  year={2014},
  volume={8},
  pages={2449 - 2462}
}
  • Yin Zhu, M. Cheng, +7 authors N. Lu
  • Published 2014
  • Biology, Medicine
  • Drug Design, Development and Therapy
Mesenchymal stem cells (MSCs) have been recognized as promising delivery vehicles for gene therapy of tumors. Gastric cancer is the third leading cause of worldwide cancer mortality, and novel treatment modalities are urgently needed. NK4 is an antagonist of hepatocyte growth factor receptors (Met) which are often aberrantly activated in gastric cancer and thus represent a useful candidate for targeted therapies. This study investigated MSC-delivered NK4 gene therapy in nude mice bearing… Expand
Effects of human placenta‐derived mesenchymal stem cells with NK4 gene expression on glioblastoma multiforme cell lines
TLDR
Examination of the antitumor effects of manipulating human placenta‐derived mesenchymal stem cells with NK4 expression with PDMSC‐NK4 on GBM cells suggested that PDMSCs can also be applied as an ideal cellular vehicle to target the glioblastoma multiforme. Expand
Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment
TLDR
Mesenchymal stem cells are non-hematopoietic progenitor cells, which can be isolated from different types of tissues including bone marrow, adipose tissue, tooth pulp, and placenta/umbilical cord blood, and are considered as a new therapeutic agent and drug delivery vector. Expand
Umbilical cord‐derived mesenchymal stromal/stem cells expressing IL‐24 induce apoptosis in gliomas
TLDR
Findings indicate that UC‐MSC‐based IL‐24 gene therapy may be able to suppress the growth of glioma xenografts, thereby suggesting possible future therapeutic use in the treatment ofgliomas. Expand
Mesenchymal stem cells as professional actors in gastrointestinal cancer therapy: From Naïve to genetically modified
TLDR
The characteristics and utility of Mesenchymal stem cells in cancer therapy are overviewed, the application of naïve MSCs and utilization of M SCs in the delivery of therapeutic agents in GI cancer therapy is discussed, and more information about harnessing of genetically modified MSCS inGI cancer treatment will be presented. Expand
The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts.
TLDR
The current state of MSC-based therapeutic approaches for cancer is summarized, and the remaining questions, obstacles and risks, as well as novel developments such as M SC-derived nanoghosts are described. Expand
MSCs loaded with oncolytic reovirus: migration and in vivo virus delivery potential for evaluating anti-cancer effect in tumor-bearing C57BL/6 mice
TLDR
The results showed that the cell carrier strategy using oncolytic reovirus-loaded AD-MSCs enhanced virus delivery, infiltration, and antitumor activity can be effectively applied in most cancers. Expand
Harnessing mesenchymal stem cell homing as an anticancer therapy
TLDR
This review will focus on the current developments of MSC-based gene therapy, in particular the diverse approaches that have been used for MSCs-targeted tumor therapy and some outstanding issues. Expand
Engineered mesenchymal stem cells as vectors in a suicide gene therapy against preclinical murine models for solid tumors.
TLDR
Ex vivo and in vivo investigations showed that MSCs expressing CYP2B6TM-RED were able to bioactivate CPA and produce local cytotoxic metabolites in tumor sites and to destroy neighboring tumor cells through a bystander effect, suggesting that M SCs expressing CyP2 B6 TM-RED with CPA could represent a promising treatment for solid tumors to test in future clinical trials. Expand
Mesenchymal Stem Cells as Vectors for Cancer Therapy
TLDR
In this chapter, updated information on the applications of engineered MSCs for cancer therapy will be discussed. Expand
Mesenchymal Stem Cells in Gastric Cancer: Vicious but Hopeful
TLDR
Current advances concerning the reciprocal metabolic interactions between MSC and GC and their underlying therapeutic implications in the future are summarized. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 88 REFERENCES
Chemotaxis of bone marrow-derived mesenchymal stem cells to gastric cancer cells in vivo and in vitro
TLDR
The chemotaxis of hB MSC to gastric cancer is obvious and specific, and hBMSC may be a good vehicle for gene therapy of Gastric cancer. Expand
Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells
TLDR
MSC-based gene therapy did not induce the severe adverse effects induced by conventional adenoviral vectors, indicating that MSCs can serve as a vehicle of gene therapy for targeting multiple lung metastatic tumors. Expand
Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model
TLDR
This is the first study that demonstrates the potential therapeutic utility of Ad.TR‐transduced MSCs in cancer cells and the stability of this vector in the context of the blood environment. Expand
Stem and progenitor cell-mediated tumor selective gene therapy
TLDR
It is demonstrated that neural and mesenchymal stem cells can deliver therapeutic genes to elicit a significant antitumor response in animal models of intracranial glioma, medulloblastoma, melanoma brain metastasis, disseminated neuroblastoma and breast cancer lung metastasis. Expand
Cancer gene therapy using mesenchymal stem cells
TLDR
The potential of MSCs as cellular vehicles for targeted cancer therapy and the molecular mechanisms underlying MSC accumulation at tumor sites are reviewed. Expand
Inhibition of colon cancer growth and metastasis by NK4 gene repetitive delivery in mice.
TLDR
Inhibition of the HGF-Met receptor pathway and tumor angiogenesis by NK4 gene expression has potential therapeutic value toward inhibition of invasion, growth, and metastasis of colon cancer. Expand
Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival
TLDR
Peritumoral injection of Ad-NK4 plus GEM is a potent combination therapy for pancreatic cancer, and Histologic and immunohistochemical assays of primary tumors indicated that combination therapy prohibited both cell proliferation and angiogenesis, resulting in high levels of apoptosis. Expand
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
TLDR
It is shown that mesenchymal stem cells supported tumour angiogenesis in vivo, that is CD31+ vessel density was increased after the transfer of MSC compared with siVEGF-MSC, and a supportive role inAngiogenesis is suggested. Expand
Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice.
TLDR
NK4 inhibited tumor cell motility and angiogenesis, greatly suppressing growth of HUH7 tumors transplanted into mouse liver, and showed apparent promise for treatment of hepatocellular carcinoma. Expand
Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
AIM To investigate the suppressive effects of adenoviral vector-mediated expression of NK4, an antagonist of hepatocyte growth factor (HGF), on human colon cancer in an athymic mouse model to exploreExpand
...
1
2
3
4
5
...